We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Demonstrates How Labs Can Enhance QC Efficiencies at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is attending Medlab Middle East 2023 where it is demonstrating how laboratories can enhance their quality control (QC) efficiencies through automated processes with independent QC and QC data management.

Under LGC Clinical Diagnostics Group, the company’s booth at this year’s Medlab Middle East is representing the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. LGC is presenting its comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials with representatives from each company available to answer all the questions of visitors at its booth.

At Medlab Middle East 2023, LGC is showcasing Technopath’s total QC solution, Multichem QC and IAMQC software that provide clinical laboratories with significant cost, handling and time savings, whilst delivering higher confidence in analytical testing methods. With an extensive list of analytes included in the Multichem range of QC products, choice and flexibility are guaranteed for all customers. The third party QC products include General Clinical Chemistry, Immunoproteins, Immunoassay, Cardiac, Urine Chemistry, Infectious Disease, Diabetes and other Esoteric controls. The controls are offered in assayed and unassayed formats. Technopath’s human based control matrix offers unrivalled test consolidation through increased control stability and diminished matrix effects. Together, these aspects of control manufacture offer greater control efficiencies without compromising compliance or confidence in patient results.

LGC is also demonstrating the IAMQC Software from Technopath that provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Software tools allow users to automate, centralize, standardize and improve QC processes in a laboratory setting. A combination of modules satisfies the varying levels of QC requirements in individual laboratories and is easily tailored to meet different QC management expectations. This also includes the new IAMQC Infinity that incorporates all the functionality of IAMQC Peer, Daily and Expert in one application. The powerful cloud based software designed to exactly meet specific QC solution needs has a feature-based interface that allows the laboratory to build their custom solution and then to seamlessly add in further sophisticated features as and when needed.

Related Links:
LGC

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.